Daniel Ives is the founder of Shift Bioscience, a longevity biotech company that targeting aging from mitochondrial DNA dysfunction and epigenetic screens.
Longevitytech.fund is a longevity-focussed venture capital firm based in the Czech Republic. In this episode we discuss their investment philosophy and views on the growing longevity economy.
Aubrey de Grey is the founder of SENS Research Foundation and the author of Ending Aging. His popularization of engineered approaches for repairing aging damage has inspired countless many to join the fight against aging.